To determine whether high‐throughput sequencing of the TCRβ‐CDR3 region can assist in tracking tumor‐associated antigen‐specific T cells, we interrogated the clonal repertoire of EBV‐specific CD8+ T cells from a patient with EBV+ DLBCL. Here, CD8A is linked to diffuse large B-cell lymphoma.